No Result
View All Result
Saturday, January 2, 2021
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
  • |
  • Tech
  • Medicine
  • Society
  • Environment
  • Spazio
  • Transportation
  • Weather
  • concepts
  • H+
No Result
View All Result

Covid-19 Updates »

November 10, 2019
in Medicine

The celiac disease vaccine enters the second test phase

Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

CONTACT US
The celiac disease vaccine enters the second test phase
Share18Pin1Tweet3SendShare1
tags: celiac diseasegluten-freevaccines
Gianluca Ricciodi Gianluca Riccio
2 minutes of reading

The last

3 pillars that make 2021 the year of the Great Reset

Engineers use AI to convert ancient maps into satellite images

Woe to Liars: Science Finds an Ethical Way to Detect Lies

Trams powered by waste on small routes? The future of biomethane

Kuno, the ecological fridge that works without electricity

Read also:

Pentagon and UFO

USA, in the 2021 bill an ultimatum to the FBI on the UFO phenomenon

Recalibrate, the watchword for 2021

Recalibrate, the watchword for 2021

Aliens, here's what we learned about them in 2020

Aliens, here's what we learned about them in 2020

gray laptop computer on brown wooden table beside person sitting on chair

6 reasons why smartworking 2021 will be better

black 3d printed motorcycle

Black e-bike, 3D printed electronic motorcycle with a bad face

The speaker for the mood with music and aromatherapy? An olfactory Nespresso

The speaker for the mood with music and aromatherapy? An olfactory Nespresso

house of wood, straw and cork

A house of wood, straw and cork: LCA and the “barn” of the third millennium

Deeper Smart Sonar Pro +, fishing with the mini depth sounder

Deeper Smart Sonar Pro +, fishing with the mini depth sounder

Rootine, personalized vitamins based on DNA

Rootine, personalized vitamins based on DNA

A UV-LED kills Covid. The team: "Let's use it in ventilation systems"

A UV-LED kills Covid. The team: "Let's use it in ventilation systems"

Street Art, Leon Keer's crazy 3D mural comes to life in AR

Street Art, Leon Keer's crazy 3D mural comes to life in AR

Birth rate Italy, Covid knocks it down to the lowest levels ever

Birth rate Italy, Covid knocks it down to the lowest levels ever

Read also:

3 pillars that make 2021 the year of the Great Reset

3 pillars that make 2021 the year of the Great Reset

The disorder, which now affects 1% of the population, could be numbered in years. A celiac disease vaccine can solve the problem.

Not just the promising tests on the colorectal cancer vaccine, or those on "contagious" vaccines that extend coverage to subjects other than the vaccinated one: recent advances in vaccine research also include the development of a celiac disease medication that solves all problems related to the ingestion of gluten.

The treatment, called Nexvax2 and developed by biotech firm ImmusanT, it's a type of immunotherapy that the developers say aims to reprogram the immune system to make it gluten tolerant.

Maybe you are also interested

Will the anti-Covid effort give us a "universal" flu vaccine?

Vaccertify, Seattle-based startup creates the prototype of the "vaccine passport"

Sputnik vaccine for Covid-19, all the doubts in the world

New cancer vaccine, other steps forward: now human tests

Celiac disease: a bad customer

Gluten, a protein based on wheat, barley and rye, causes negative reactions in more and more people by damaging the intestines. The estimate has now risen to one celiac per 100 inhabitants.

Currently the only remedy for celiac disease is to avoid foods that contain gluten. This has led to the growth in popularity of an entire market based on gluten-free products. Yet diets of this type continue to be neither comfortable nor cheap, and still present many risks of accidental exposure.

Nexvax2 works not unlike that of antiallergic therapies. The treatment involves two injections per week for a period of 16 weeks, and is based on molecules called peptides, capable of stimulating an immune response in the patient who ends up tolerating gluten.

The vaccine is designed for patients with a particular immune system gene called HLA-DQ2.5 present in 90% of cases. The first tests aimed to demonstrate his safety and good patient tolerance.

The next phase of Nexvax2 will involve around 150 patients and will also aim to evaluate the precise efficacy of the treatment.

"This new phase is important in establishing the best efficacy of a vaccine compared to a mere gluten-free diet," says Jason Tye-Din, head of the celiac disease research department ofHall Institute of Medical Research in Australia.

The dr. Jason Tye-Din and Dr. Melinda Hardy

As reported by the portal ClinicalTrials.govImmusanT is asking for the collaboration of volunteer patients in America, Australia and New Zealand. For them the prospect of an economic contribution, of healing from celiac disease and finally a nice sandwich as it should be.

Comment this post on all the social networks where Futuroprossimo.it is present ( Facebook, Instagram, Twitter, Telegram, Linkedin, Vkontakte, Flipboard )

The future of:

Artificial intelligence

Japan will launch a dating service: here is the state Tinder (with AI)

transhumanism

A special hyperbaric therapy can stop and reverse aging

Super Gadgets

Out Of, the Italian startup is sold out with the photovoltaic ski mask

Design

The Tulip, the spectacular “tulip” skyscraper in London

Most read of the week

  • Street Art, Leon Keer's crazy 3D mural comes to life in AR

    Street Art, Leon Keer's crazy 3D mural comes to life in AR

    275 shares
    Share 110 Tweet 69
  • “Honey made without bees”: MeliBio, botany and biology

    385 shares
    Share 154 Tweet 96
  • KSTAR, the Korean artificial sun sets a new record

    141 shares
    Share 56 Tweet 35

The last

This mobile hospital travels on wheels to treat patients faster

Why Christmas decorations in Saudi Arabia are epochal news

First study on the mutation of Covid in the UK: good and bad news

KSTAR, the Korean artificial sun sets a new record

Jupe, a luxury retreat created by the all-star team of former Tesla, SpaceX and AirBnB

Next article
Experts warn: don't fall in love with a robot. The story of Jibo

Experts warn: don't fall in love with a robot. The story of Jibo

Futuroprossimo.it is an Italian resource of futurology opened since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Environment Architecture Communication concepts Advice Energy Events Gadgets The future of yesterday The newspaper of tomorrow Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

Categories

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Home / Author / IDEA / archive / Advertising on FP

© 2020 Futuroprossimo - Tailored by Be Here

© 2020 Futuroprossimo - Tailored by Be Here

  • Home
  • Contact us
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Environment
  • transhumanism

© 2019 Futuroprossimo - Tailored by To be here

This site uses cookies. By continuing to read it, you consent to their use.